Lyndra Therapeutics has appointed Örn Almarsson to serve as its chief technology officer. Almarsson joins Watertown, MA-based Lyndra from Moderna (NASDAQ: [[ticker:MRNA]]), where he was head of delivery sciences. He was previously vice president of pharmaceutical R&D at Alkermes (NASDAQ: [[ticker:ALKS]]). Lyndra has reached clinical trials testing a drug delivery technology that turn daily pills into extended-release formulations.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
